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Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK 
activity and motility-suppressive ability*
Zhou, Qinghua1 Yang, Xueqin2 Zhu, Daxing3 Ma, Li3 Zhu, Wen4 
1 Tianjin Lung Cancer Institute,Tianjin Medical University General 
Hospital, Tianjin, China 2 Cancer Center, West China Hospital, Sichuan 
University, Chengdu, China 3 Tianjin Lung Cancer Center, Tianjin 
Medical Unversity General Hospital, Tianjin, China 4 Key Lab. of Lung 
Cancer Molecular Biology of Sichuan Province,West China Hospital, 
Sichuan University, Chengdu, China 
Background: The Nm23-H1 gene is a metastasis suppressor gene. 
However, its biochemical mechanism of suppressing the met static 
potential of cancer cells is still unknown. The previous hypothesis that 
a histidine protein kinase activity may contributes to the motility-sup-
pressive effect of Nm23-H1 could not explain why the H118F mutant, 
a kinase-deﬁcient mutant, still had motility-suppressive ability. 
Methods: We conducted a study on the double mutant P96S/S120G 
of Nm223-H1 and succeeded in introducing the RP-HPLC method in 
NDPK assay. 
Results: The results showed that double mutant P96S/S120G, when 
expressed in the bacteria, was completely aggregated in inclusion 
bodies; prompted that the deﬁciency of motility-suppressive fuction of 
S120G, P96S, and P96S/S120G mutants was due to their altered struc-
ture, which might deprive Nm23-H1 of most activities including kinase 
activity or interactions with other proteins.
Conculsions: Double mutant P96S/S120G of Nm23-H1 abrogates its 
NDPK activity and motility-suppressive ability in the human high-
metastatic large cell lung cancer cell line L9981.
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(No. 20040610060) .
P2-036 BSTB: Cancer Genetics Posters, Tue, Sept 4 
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Background: The integrin α11 subunit is commonly overexpressed 
in non-small cell lung carcinoma (NSCLC). α11β1 integrin is a one of 
the four receptors for interstitial collagen. Immunoﬂuorescence study 
localized the protein mainly to the tumor stroma. α11 is also commonly 
overexpressed in cancer-associated ﬁbroblasts. We hypothesized that 
stromal expression of α11 may play important role in regulating the 
tumor formation of NSCLC cells. 
Methods: SV40 immortalized mouse embryonic ﬁbroblasts established 
from the wild type (WT) and α11 deﬁcient (KO) mice were tested for 
their tumorigenicity in immune deﬁcient mice when co-implanted with 
the A549 human lung adenocarcinoma cells. Fibroblasts and A549 
alone served as controls. Total cellular RNA was isolated from tumors 
formed and proﬁled using the Affymetrix U133A microarray, and 
differentially expressed genes were identiﬁed. Stable gene expression 
downregulation was accomplished by retroviral mediated transduction 
of short hairpin (sh) RNA. 
Results: A549 co-implanted with the ﬁbroblasts showed markedly 
increased tumor growth rate as compared with all control cell lines 
alone, which formed only small tumors. Importantly, the growth was 
signiﬁcantly greater for A549+WT compared to A549+KO tumors. The 
reduced tumorigenicity was also rescued by re-expression of human 
α11 in KO ﬁbroblasts. The tumor-promoting effect of ﬁbroblast α11 
was reproduced in 2 other NSCLC cell lines: NCI-H460 and -H520. 
Gene expression proﬁling indicated that IGF2 mRNA expression level 
was tightly regulated by alpha-11 in the ﬁbroblasts, and A549+KO tu-
mors expressed >200-fold lower IGF2 compared to A549+WT tumors. 
The shRNA downregulation of IGF2 in WT (WTsh-IGF2) ﬁbroblasts 
resulted in decreased growth rate of A549+WTsh-IGF2 compared to 
A549+WT tumors. In the orthotopic NCI-H460 human lung cancer 
model, host stromal α11 expression was signiﬁcantly higher in meta-
static compared to the primary tumors. 
Conclusion: Integrin α11 expressed on tumor stromal ﬁbroblasts 
provide a novel and alternate mechanism for collagen to modulate the 
growth of NSCLC cells, and IGF2 is one of the mediators for such 
activity. 
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Reverse transcriptase polymerase chain reaction assay designed 
for the detection of LUNX-mRNA to compare the micrometastasis 
during chemotherapy in patients with non-small cell lung cancer
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Objective: To compare the micrometastasis during chemotherapy in 
patients with non-small cell lung cancer. 
Material and Methods: To detect the expression of the lung tissue 
speciﬁc gene named LUNX with reverse transcriptase chain reaction 
method (RT-PCR) in peripheral blood of patients with non-small cell 
lung cancer (NSCLC), the micrometastasis of non-small cell lung 
cancer was diagnosed. 
Result: Total 20 patients was involved in the study, the peripheral 
blood was sampled before and after two cycles chemotherapy. There 
were 7 patients with NSCLC showed LUNX gene expression in blood 
before chemotherapy by RT-PCR.After two cycles of chemotherapy, 
there were 2 patients who was positive in blood detection. The positive 
detection rate of in peripheral blood in the group of before chemother-
